Technology News and Research

RSS

Cangene announces development of Immune Globulin Intravenous product

Cangene Corporation today announces that it is developing an Immune Globulin Intravenous product, commonly known as IGIV. IGIV is a widely used anti-infective with a variety of indications including treating primary immune deficiency, immune thrombocytopenic purpura and other inflammatory and autoimmune diseases.

15 Jun 2010

IRIN, IPS examine pending U.S. legislation to address global hunger, FGM

IRIN reports on the Global Food Security Act, a bill aimed at expanding the U.S. government's role in combatting hunger around the world. The legislation is co-sponsored by Sens. Richard Lugar (R-Ind.) and Bob Casey (D-Pa.).

15 Jun 2010

ExonHit Therapeutics, Genmab A/S sign agreement for selection of novel splice variants

ExonHit Therapeutics today announced the signing of an exclusive agreement with Genmab A/S for a selection of novel splice variants, identified as part of a successful pilot study, that have the potential to be therapeutic targets for breast cancer. Genmab retains exclusive development and commercialization rights on 10 events out of a breast cancer database developed using ExonHit's genome-wide SpliceArray technology (RNA splicing analysis platform covering the entire genome).

15 Jun 2010

Entomologists to develop genetically engineered bacteria for killing mosquito larvae

Roughly half the world's population still lives in areas at risk of malaria transmission. Even in the United States, 1500 cases of malaria are reported annually on average.

15 Jun 2010

VA Federal Supply Schedule Service approves CTT as vendor for Calmare Pain Therapy Treatment

Competitive Technologies, Inc. announced today that the Department of Veterans Affairs' Federal Supply Schedule Service has accepted CTT's application to be an approved vendor for its Calmare® Pain Therapy Treatment. This decision will enable CTT to sell Calmare Pain Therapy to physicians throughout the Federal government, with the expectation of significant sales in that market sector, which includes the Department of Veterans Affairs, the Department of Defense, the Indian Health Service, the Bureau of Prisons, and State Veteran Homes.

15 Jun 2010

Behind the Numbers report: Employers' medical costs to increase by 9% in 2011

The nation's employers can expect medical costs to increase by 9 percent in 2011, a decrease of 0.5 percent from the 2010 growth rate, according to the annual Behind the Numbers report published today by the PricewaterhouseCoopers LLP Health Research Institute. For the first time, the majority of the American workforce is expected to have a health insurance deductible of $400 or more, as more employers return to "indemnity style" cost-sharing by raising out-of-pocket limits, replacing co-pays with co-insurance and adding high-deductible health plans.

15 Jun 2010

ICON, PAREXEL to provide global support for execution of Bristol-Myers Squibb's clinical studies

Bristol-Myers Squibb Company today announced that it has signed agreements with ICON and PAREXEL, two leading providers of clinical development services to the biopharmaceutical industry, for joint strategic, operational and capability support of the company's clinical development program.

From Parexel 15 Jun 2010

ConvaTec presents Vitala Continence Control Device Phase 2 data at 2010 WOCN/WCET joint conference

ConvaTec, a world-leading developer of innovative medical technologies for community and hospital care, today presented data supporting the safety and efficacy of Vitala™, a novel, non-intrusive pouchless ostomy device that provides temporary continence to people with a colostomy. The clinical trial data were presented at the 2010 Joint Conference of the Wound, Ostomy and Continence Nurses Society (WOCN) and World Council of Enterostomal Therapists (WCET), where the new device is being previewed to U.S. and global healthcare professionals.

15 Jun 2010

Aesculap receives FDA clearance for SterilContainer product line for use in STERIS V-PRO systems

Aesculap, Inc. is pleased to announce that the SterilContainer S product line has been cleared by the United States Food and Drug Administration (FDA), (510(k) number, K093649) for use in the STERIS Corporation's V-PRO 1 and V-PRO 1 Plus Low Temperature Sterilization Systems.

14 Jun 2010

PAREXEL, Bristol-Myers Squibb establish strategic partnership in clinical development

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that Bristol-Myers Squibb, a global biopharmaceutical company, has established a strategic partnership with PAREXEL to enable greater effectiveness in clinical development.

From Parexel 14 Jun 2010

New Brunswick Scientific, Pall partner to develop new disposable bioreactor systems

New Brunswick Scientific, an Eppendorf Company, and Pall Corporation today announced a joint product development and marketing agreement to create and supply new disposable bioreactor systems.

From Pall Corporation 14 Jun 2010

Fluorescent cancerous tumors for early detection

Researchers at the Ecole Polytechnique F-d-rale de Lausanne (EPFL) in Switzerland have established a procedure where cancerous tumors in the bladder become fluorescent and are more easily discoverable under blue light. The Food and Drug Administration (FDA) approved the technique- already in practice in Europe - for the American market. Under the name Cysview-, the product is commercialized by Photocure and GE Healthcare as the most efficient detection technique for early stage bladder cancer.

14 Jun 2010

Desert Medical Imaging to implement XIFIN's revenue cycle management system

XIFIN Inc., the leading provider of revenue cycle management for diagnostic service providers, announced today that Desert Medical Imaging, (DMI) a multi-modality diagnostic imaging center located in Indian Wells, CA, has selected XIFIN's revenue cycle management system to optimize and help manage its expanding imaging and radiology billing and claims management needs.

14 Jun 2010

MP Biomedicals to acquire ICPbio International

MP Biomedicals LLC announced today that it has signed a definitive agreement to acquire the assets of ICPbio International LTD., an Auckland, New Zealand based protein biologics manufacturing company, subject to normal closing adjustments. This acquisition places MP Biomedicals in a strong position to pursue sales and distribution of serum protein products used in research and manufacturing in the Biopharmaceutical, In vitro diagnostic and Biotech sectors.

From MP Biomedicals, LLC 14 Jun 2010

Upsher-Smith commences global USL255 Phase III clinical trial for management of epilepsy

Upsher-Smith Laboratories, Inc. today announced the initiation of a global Phase III clinical trial for USL255 (extended-release topiramate), an internally developed program for the management of epilepsy in adults, using the company's proprietary formulation technology. USL255 is designed to provide convenient once-daily dosing and reduce fluctuations in topiramate blood levels observed with currently available topiramate options.

14 Jun 2010

WoundVision launches bedside thermographic imaging system

WoundVision™, the healthcare industry pioneer in advanced wound detection technology, is introducing today a revolutionary predictive bedside thermographic imaging system. The WoundVision system brings knowledge bedside by acquiring, analyzing and applying essential patient data to inform healthcare providers in the development of effective treatment and care plans.

14 Jun 2010

BioAMD establishes headquarters at Daresbury SIC

Flex Fuels Energy, Inc. announced today that its subsidiary, BioAMD Holdings Ltd., has established its headquarters at the prestigious Daresbury Science and Innovation Campus in the United Kingdom. BioAMD is in the $12.6 billion Point-of-Care medical diagnostics industry.

14 Jun 2010

BioScale secures $25 million for commercialization of ViBE protein analytics systems

BioScale Inc., a privately-held life science company that develops, manufactures and promotes a new generation of protein analytics technology, today announced that it has secured $25 million in its recent financing round. Led by new investor Morningside Venture, this round will be used to expand manufacturing operations and commercial sales of the ViBE protein analytics systems. Also participating in the financing were existing investors New Science Ventures, WFD Ventures, F2 Ventures, and several individual investors

14 Jun 2010

HCL Infosystems, Wellogic partner to create India's National Health Information Exchange Environment

HCL Infosystems, India's premier information technology company and Wellogic, a renowned healthcare interoperability and point-of-care solutions provider, today announced that they are working together to create India's National Health Information Exchange Environment (INHIEE), and seeding adoption via Wellogic's world-class portal, electronic health record (EHR), and personal health record (PHR) solutions.

14 Jun 2010

Agile Therapeutics completes $45 million Series B Preferred Stock financing round

Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.

14 Jun 2010

Technology News and Research

Cangene announces development of Immune Globulin Intravenous product

IRIN, IPS examine pending U.S. legislation to address global hunger, FGM

ExonHit Therapeutics, Genmab A/S sign agreement for selection of novel splice variants

Entomologists to develop genetically engineered bacteria for killing mosquito larvae

VA Federal Supply Schedule Service approves CTT as vendor for Calmare Pain Therapy Treatment

Behind the Numbers report: Employers' medical costs to increase by 9% in 2011

ICON, PAREXEL to provide global support for execution of Bristol-Myers Squibb's clinical studies

ConvaTec presents Vitala Continence Control Device Phase 2 data at 2010 WOCN/WCET joint conference

Aesculap receives FDA clearance for SterilContainer product line for use in STERIS V-PRO systems

PAREXEL, Bristol-Myers Squibb establish strategic partnership in clinical development

New Brunswick Scientific, Pall partner to develop new disposable bioreactor systems

Fluorescent cancerous tumors for early detection

Desert Medical Imaging to implement XIFIN's revenue cycle management system

MP Biomedicals to acquire ICPbio International

Upsher-Smith commences global USL255 Phase III clinical trial for management of epilepsy

WoundVision launches bedside thermographic imaging system

BioAMD establishes headquarters at Daresbury SIC

BioScale secures $25 million for commercialization of ViBE protein analytics systems

HCL Infosystems, Wellogic partner to create India's National Health Information Exchange Environment

Agile Therapeutics completes $45 million Series B Preferred Stock financing round

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News